For example, the multikinase blocker palbociclib is used in combination with endocrine therapy for hormone receptor–positive breast cancer [77], but we do not have solid information on the efficacy in the case of intracranial dissemination [45]. The gene discussed is NR4A1; the disease is breast carcinoma.